NEPH - Nephros GAAP EPS of -$0.31 misses by $0.20 revenue of $2.41M misses by $0.11M
- Nephros press release ( NASDAQ: NEPH ): Q3 GAAP EPS of -$0.31 misses by $0.20 .
- Revenue of $2.41M (-8.4% Y/Y) misses by $0.11M .
-
Net loss from continuing operations for the quarter ended September 30, 2022, was $1.3 million, compared to $0.8 million during the same period in 2021. The increase in net loss from continuing operations was driven by changes to inventory reserve estimates.
-
Adjusted EBITDA loss from continuing operations for the quarter ended September 30, 2022, was ($0.3 million), compared to ($0.4 million) during the same period in 2021.
-
Cost of goods sold for the quarter ended September 30, 2022 was $1.6 million, compared with $1.2 million for the quarter ended September 30, 2021, an increase of 35%.
For further details see:
Nephros GAAP EPS of -$0.31 misses by $0.20, revenue of $2.41M misses by $0.11M